"Global Oncology Drugs market set to grow to $173bn by 2024," says new Visiongain report

CROYDON, U.K. - May 29, 2019 - PRLog -- The anti-cancer drugs market will continue to increase over the next 10 years, as the incidence of cancer rises around the world. Growth will be driven by the ageing population in both the developed and developing markets. Better accessibility to healthcare and new diagnostic techniques has allowed more cancer cases to be discovered when they can be more easily treated. Continuous research and development will lead to more treatments being available on the market, although the number of big blockbuster drugs will fall as treatment becomes more personalised.

The lead analyst of the report commented "The cancer treating drugs market will continue to grow over the next ten years. Despite generic erosion due to patent expiry on some leading anti-cancer drugs, this market will gain successful new products, including orphan drugs for rare cancers. Many R&D studies focus on immunotherapy and targeted therapy, in line with the increasing interest in personalised medicine."

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on 020 7549 9987

Leading companies featured in the report include Abbott Laboratories, AbbVie, Amgen, Astellas Pharma, AstraZeneca, Aurora Biophama, Boehringer Ingelheim, Bristol-Myers Squibb (BMS), Celgene Corporation, Eli Lilly, Fresenius Kabi and other companies.

Related reports:

Global Cancer Immunotherapy Market Forecast 2019-2029

Global Biosimilars and Follow-On Biologics Market 2019-2029

Global Blood Cancer Market Forecast to 2028

For more pharma reports, visit our website:
https://www.visiongain.com/industries/pharma/

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on 020 7549 9987

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.